NOBIVAC® Edge DAPPv+L4
NOBIVAC EDGE DAPPv+L4 provides proven protection against several common viruses and enhanced quality in leptospirosis protection.
LEARN MORENOBIVAC EDGE® DAPPv
Approved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.
LEARN MOREBOVILIS® CAVALRY® 9
For the vaccination of healthy cattle against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. tetani, and C. perfringens Types C & D.
LEARN MOREBOVILIS® 20/20 VISION® 7 WITH SPUR®*
For use in healthy cattle as an aid in preventing Clostridium chauvoei, septicum, novyi, sordellii and perfringens (Types C & D), and Moraxella bovis.
LEARN MORENUFLOR®-S (florfenicol)
For treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, Streptococcus…
LEARN MORENUFLOR® INJECTABLE SOLUTION
For treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
LEARN MORENobivac® Puppy-DPv
For the vaccination of healthy puppies for the prevention of disease caused by canine distemper virus and CPV.
LEARN MORENOBIVAC® Lyme
For vaccination of healthy dogs 8 weeks or older against Borrelia burgdorferi. Duration of Immunity is at least 1 year.
LEARN MORENOBIVAC® Lepto₄
For vaccination of healthy dogs against Leptospira canicola, L. icterohaemorrhagiae, L. pomona and L. grippotyphosa.
LEARN MORENOBIVAC® Intra-Trac®₃ ADT
Intranasal vaccine with Advanced Delivery Technology for healthy dogs against canine adenovirus (Type 2), CPIV, and Bordetella bronchiseptica.
LEARN MORENOBIVAC® Intra-Trac®₃
Intranasal vaccine for healthy dogs against canine adenovirus (Type 2), CPIV, and Bordetella bronchiseptica.
LEARN MORENOBIVAC® Intra-Trac® Oral BbPi
Our proprietary formulation and patented Immuno-Mist-Râ„¢ technology make it possible.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global